US · guidance
CMS Pub. 100-04, ch. 17, § 80.1.1
HCPCS Service Coding for Oral Cancer Drugs
The following codes may be used for drugs other than Prodrugs, when covered:
Generic/Chemical Name How Supplied HCPCS
Busulfan 2 mg/ORAL J8510
Capecitabine 150mg/ORAL J8520
Capecitabine 500mg/ORAL J8521
Methotrexate 2.5 mg/ORAL J8610
Cyclophosphamide * 25 mg/ORAL J8530
Cyclophosphamide *
(Treat 50 mg. as 2 units
50 mg/ORAL J8530
Generic/Chemical Name How Supplied HCPCS
Etoposide 50 mg/ORAL J8560
Melphalan 2 mg/ORAL J8600
Prescription Drug chemotherapeutic
NOC
ORAL J8999
Each tablet or capsule is equal to one unit, except for 50 mg/ORAL of cyclophosphamide (J8530),
which is shown as 2 units. The 25mg and 50 mg share the same code.
NOTE: HIPAA requires that drug claims submitted to DME MACs be identified by NDC.
History
(Rev. 1, 10-01-03)
Provenance
- Source
- cms.gov
- Retrieved
- 2026-08-25
- Edition
- iom-2026-08-25
- Content hash
a8001ac89c84530d4312e91ad045c0356cd44f6fd2fefe24a36ebd6207153ee2
The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.
Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.